Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D formulary changes

Executive Summary

CMS will accept negative formulary change requests from Medicare Part D plan sponsors for the 2007 benefit year until July 31, but the agency can only guarantee that what are considered to be "maintenance" change requests will be reviewed, according to a June 20 1memo to sponsors. Maintenance revisions might include moving a brand name product to a less preferred tier after a generic version is approved or changes for safety reasons. The agency also will allow sponsors to request certain types of changes from Aug. 8-10 in the Part D formularies that have already been submitted for 2008. "Allowable" changes specified in the memo include deletion of a drug along with the corresponding addition of a drug within the same USP class at the same, or lower, beneficiary cost-sharing level...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048547

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel